Modified transplantation system

DRUG2 trials

Sponsors

Hematology department of the 920th hospital

Conditions

Aplastic AnaemiaSevere Aplastic AnemiaTransplantation Conditioning

Phase 2

Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia

RecruitingNCT06378060

Hematology department of the 920th hospitalSevere Aplastic Anemia

Start: 2024-03-01End: 2027-04-01Target: 30Updated: 2024-04-22

Unknown Phase

Modified Transplantation Regimen and aGVHD Prophylaxis for Severe Aplastic Anemia in the Setting of Allogeneic HSCT.

CompletedNCT06837987

Hematology department of the 920th hospitalAplastic Anaemia, Transplantation Conditioning

Start: 2020-06-01End: 2025-08-01Updated: 2025-09-22

Related Papers

Fludarabine, cyclophosphamide, and melphalan (FCM) preconditioning in haploidentical hematopoietic stem cell transplantation for severe aplastic anemia: Update of a prospective, multicenter, single-arm clinical study

Blood2025-11-03